Regulators Focus Pharmacy Checks on Risk
Uzbek and UK regulators discussed risk-based pharmacy inspection, a method that targets the highest-risk sites first.
Updated on Nov. 5, 2026 in Asthma
Uzbek pharmaceutical regulators met online on 4 November with a representative of the UK General Pharmaceutical Council to discuss risk-based approaches to pharmacy inspection. Staff from the Centre for Good Practices under the Agency for the Development of the Medical and Pharmaceutical Industry of Uzbekistan took part in the discussion.
Why it matters
Risk-based inspection directs regulatory attention toward the pharmacies and processes most likely to cause harm, which bears on how reliably patients receive safely dispensed medicines, including inhaled treatments used for asthma. The exchange reflects an effort to strengthen supervisory procedures across borders.
The information comes from a summary of a single online meeting between regulatory staff, with no outcome measures or quantitative data reported. Because it describes a discussion rather than a study, no effect sizes or sample populations are available.
The players
General Pharmaceutical Council (GPhC)
The UK's independent regulator of pharmacists, pharmacy technicians, and pharmacies, responsible for setting standards and overseeing pharmacy practice.
Agency for the Development of the Medical and Pharmaceutical Industry of Uzbekistan
Uzbekistan's government agency overseeing development of its medical and pharmaceutical sector, including the Centre for Good Practices that took part in the meeting.
The details
Risk-based supervision means regulators rank pharmacies by factors such as past compliance, complexity of operations, and potential for harm, then concentrate inspection resources on the highest-risk sites rather than inspecting all sites on a uniform schedule. The approach also involves assessing risk when planning individual inspections and refining supervisory procedures over time. The meeting was held online and focused on mechanisms for overseeing pharmacy operations and on how risk assessments inform inspection planning.
Timeline
4 November 2026: Online meeting on pharmacy inspection approaches held between Uzbek and UK regulatory representatives.
Health Landscape
Risk-based inspection has become a common regulatory method for allocating limited oversight capacity across large numbers of pharmacies. Exchanges such as this one show national regulators adapting established approaches from other health systems.
Readers managing asthma should know that the safe and consistent dispensing of inhaled medicines depends in part on regulatory oversight of pharmacies. This development does not change any treatment, and any questions about your medication are best raised with your physician or pharmacist.
The takeaway
Effective pharmacy oversight helps keep medicines dispensed safely, and regulators in different countries increasingly share methods for focusing inspections where risk is highest. Asthma patients with questions about their inhaler or prescriptions can raise them with their doctor or pharmacist.
Further reading
For broader context on how inhaled treatments reach patients, see the Asthma section.
